Roundup Cancer Lawsuit News

Roundup Lawsuits See Impact In France

The country has decided to ban Roundup products in garden stores, a move that will encourage those who filed Roundup lawsuits around the U.S.

Tuesday, March 28, 2017 - The Monsanto Roundup lawsuits that have been filed recently in America have been picking up steam abroad as France has openly considered banning weed killing products that feature glyphosate as its active ingredient. The move comes after an increase in recent Roundup cancer lawsuits in the U.S., including the transfer of many of the claims into multidistrict litigation.

In addition to the growing number of Monsanto Roundup lawsuits around the country, California also recently ruled to affix a warning label to glyphosate products warning of a link between them and cancer. California is one of the largest agricultural economies in the country and the use and potential health hazard of Roundup use is escalated there compared to the rest of the country. Those developments have reverberated worldwide and caught the attention of politicians in France who have now begun to look into banning certain glyphosate products from garden stores in the interest of protecting consumers in a way Monsanto has failed to do thus far.

Roundup is Monsanto's feature herbicide and is used both personally and commercially by consumers worldwide. Plaintiffs claim that the company not only knew that their product contained a carcinogen, but that the company intentionally tinkered with certain studies and testing to fraudulently get the results they wanted. The Roundup cancer lawsuits claim that Monsanto had a responsibility to warn consumers of the true nature of glyphosate and the effect it could have on people if used too liberally or without proper care. There are even arguments that glyphosate should not be used at all because of the dangers involving cancer connected to the chemical.

Both plaintiffs and their Roundup lawyers insist in the lawsuits that warnings from Monsanto would not have only alerted consumers to the dangers of the product, but also may have dissuaded them from buying Roundup in the first place. This would have hurt the marketability of the product, and plaintiffs have argued that this is a reason Monsanto never elected to warn consumers about glyphosate.

Plaintiffs who have filed Monsanto Roundup cancer lawsuits have in many cases either gone through a number of surgeries or even passed away due to cancer they believe they contracted from glyphosate. Those plaintiffs and their estates are trying to recover damages from Monsanto for what they believe were preventable hardships they had to endure.

Monsanto thus far has denied that it did anything wrong, though evidence speaking to the contrary is mounting. Roundup lawsuits are building throughout the country as news spreads that the company lied about its knowledge that glyphosate was a cancer causing ingredient in Roundup.

California was the first state to determine that glyphosate was a cancer causing agent, and there could be more state bodies like OEHHA that may make similar designations in the future. For now, Roundup lawsuits filed federally will be transferred to the U.S. District Court for the Northern District of California, where they will be heard before Judge Vince Chhabria. The official ruling from France concerning its stance on glyphosate products has yet to become official in the country, though it has been picking up steam from the development of the litigation in the U.S.

More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.